ALVO

NASDAQStock

Alvotech

$3.55-0.18 (-4.83%)

52-Week Range

$3.54
$11.66

Key Stats

Market Cap

1.1B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.18

Volume

971.0K

Avg Volume

695.0K

Performance

1M

-31.92%

3M

-36.45%

6M

-56.40%

YTD

-29.20%

1Y

-68.87%

3Y

-73.50%

5Y

-68.36%

Price Chart

ETF Exposure

ALVO is held by 15 ETFs

ETFFund NameWeight
GLCRGlacierShares Nasdaq Iceland ETF3.61%
IDNAiShares Genomics Immunology and Healthcare ETF0.43%
IBBQInvesco Nasdaq Biotechnology ETF0.09%
BIBProShares - Ultra Nasdaq Biotechnology0.06%
IBBiShares Biotechnology ETF0.04%
STXKStrive Small-Cap ETF0.02%
VEXCVanguard Emerging Markets ex-China ETF0.01%
PRFZInvesco RAFI US 1500 Small-Mid ETF0.01%
VWOVanguard FTSE Emerging Markets ETF0.01%
ONEQFIDELITY NASDAQ COMPOSITE INDEX ETF0.00%
SCHESchwab Emerging Markets Equity ETF0.00%
VEUVanguard FTSE All-World ex-US ETF0.00%
VSGXVanguard ESG International Stock ETF0.00%
V3AL.LVanguard ESG Global All Cap UCITS ETF (USD) Distributing0.00%
VTVanguard Total World Stock ETF0.00%

About ALVO ETF Exposure

Alvotech (ALVO) is held by 15 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.1B, ALVO is a widely held institutional stock. The stock currently trades at $3.55. Investors can gain exposure to ALVO through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ALVO, sorted by portfolio weight.